UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002182
Receipt number R000001991
Scientific Title A phase II study to evaluate the effectiveness of l-LV/5-FU (mRPMI regimen) + Bevacizumab for patients with advanced/recurrent colon cancer who cannot undergo common protocol (OGSG 0802)
Date of disclosure of the study information 2009/07/10
Last modified on 2022/09/25 17:47:32

No. Disposal Last modified on Item of update
1 Insert 2009/07/10 16:35:10
2 Update 2009/07/10 16:45:24 Acronym
Acronym
3 Update 2009/12/04 17:44:16 Recruitment status
4 Update 2011/02/24 16:02:20 Recruitment status
Last follow-up date
5 Update 2012/06/24 23:54:46 Public title
Public title
Acronym
Acronym
6 Update 2012/06/24 23:57:20 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Address1
Tel1
Email1
7 Update 2013/01/10 20:25:16 Recruitment status
Last follow-up date
8 Update 2022/09/25 16:58:43 Date of IRB
Anticipated trial start date
Last follow-up date
9 Update 2022/09/25 17:28:25 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
10 Update 2022/09/25 17:41:20 Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
11 Update 2022/09/25 17:47:32 Interventions/Control_1
Interventions/Control_1